| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1032883037 |
| P356 | DOI | 10.1186/1471-2407-12-81 |
| P953 | full work available at URL | http://link.springer.com/article/10.1186/1471-2407-12-81/fulltext.html |
| http://link.springer.com/content/pdf/10.1186/1471-2407-12-81 | ||
| http://link.springer.com/content/pdf/10.1186/1471-2407-12-81.pdf | ||
| https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-12-81 | ||
| https://europepmc.org/articles/PMC3313899 | ||
| https://europepmc.org/articles/PMC3313899?pdf=render | ||
| https://link.springer.com/content/pdf/10.1186/1471-2407-12-81.pdf | ||
| P932 | PMC publication ID | 3313899 |
| P698 | PubMed publication ID | 22390300 |
| P5875 | ResearchGate publication ID | 221887984 |
| P2093 | author name string | Young-Gyu Ko | |
| Yun-Sil Lee | |||
| Minyoung Lee | |||
| Yoon-Jin Lee | |||
| Jae-Seon Lee | |||
| Yeung Bae Jin | |||
| Jung-Jin Park | |||
| P2860 | cites work | Biochimica et Biophysica Acta | Q864239 |
| KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2 | Q24318405 | ||
| Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1 | Q28138628 | ||
| The metastasis suppressor gene C33/CD82/KAI1 induces apoptosis through reactive oxygen intermediates | Q44641967 | ||
| Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung | Q46201034 | ||
| Targeting CUB domain-containing protein 1 with a monoclonal antibody inhibits metastasis in a prostate cancer model | Q46316570 | ||
| VHL down-regulation and differential localization as mechanisms in tumorigenesis | Q53375202 | ||
| Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss | Q56927898 | ||
| Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathway | Q73140746 | ||
| Prostate cancer and the met hepatocyte growth factor receptor | Q28278555 | ||
| Learning therapeutic lessons from metastasis suppressor proteins | Q30435922 | ||
| β1A integrin is a master regulator of invadosome organization and function. | Q30497504 | ||
| The C2 domain of PKCdelta is a phosphotyrosine binding domain | Q30851015 | ||
| Proteomic analysis of the tetraspanin web using LC-ESI-MS/MS and MALDI-FTICR-MS. | Q33231320 | ||
| Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta. | Q34074338 | ||
| CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis | Q34534040 | ||
| VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration | Q34549885 | ||
| Functional role of cell surface CUB domain-containing protein 1 in tumor cell dissemination. | Q34748645 | ||
| The cell surface glycoprotein CDCP1 in cancer--insights, opportunities, and challenges | Q34985908 | ||
| Role of VHL gene mutation in human cancer | Q35990141 | ||
| CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma | Q36691145 | ||
| The role of membrane microdomains in transmembrane signaling through the epithelial glycoprotein Gp140/CDCP1. | Q37083037 | ||
| Hypoxia-inducible factor 1 and cancer pathogenesis | Q37174625 | ||
| Controlling cell surface dynamics and signaling: how CD82/KAI1 suppresses metastasis | Q37281251 | ||
| Molecular mechanisms of metastasis in prostate cancer | Q37339692 | ||
| VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacy | Q37393004 | ||
| KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis | Q37395457 | ||
| Metastasis mechanisms | Q37580464 | ||
| Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes | Q37587580 | ||
| Src signaling in cancer invasion | Q37668457 | ||
| Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer | Q37724378 | ||
| Alterations in VHL as potential biomarkers in renal-cell carcinoma | Q37724576 | ||
| VEGF and prostatic cancer: a systematic review | Q37760770 | ||
| Hypoxia-mediated biological control | Q37843943 | ||
| Tetraspanin protein contributions to cancer. | Q37856398 | ||
| Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signalling | Q39799320 | ||
| Expression of the CUB domain containing protein 1 (CDCP1) gene in colorectal tumour cells | Q40163759 | ||
| Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse | Q40184546 | ||
| Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells | Q40258355 | ||
| Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases | Q40343230 | ||
| Requirement of the p130CAS-Crk Coupling for Metastasis Suppressor KAI1/CD82-mediated Inhibition of Cell Migration | Q40648952 | ||
| Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation | Q40951942 | ||
| The von Hippel-Lindau Tumor Suppressor Protein Is Destabilized by Src: Implications for Tumor Angiogenesis and Progression | Q41612038 | ||
| Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue. | Q42445195 | ||
| Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation | Q42826789 | ||
| CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation | Q43054551 | ||
| Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src | Q44049774 | ||
| von Hippel-Lindau protein complex is regulated by cell density | Q44548991 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 81 | |
| P577 | publication date | 2012-03-06 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | KAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer | |
| P478 | volume | 12 |
| Q96576951 | An oncogenic viral interferon regulatory factor upregulates CUB domain-containing protein 1 to promote angiogenesis by hijacking transcription factor lymphoid enhancer-binding factor 1 and metastasis suppressor CD82 |
| Q35908155 | Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer |
| Q49787471 | Differential tumor biological role of the tumor suppressor KAI1 and its splice variant in human breast cancer cells |
| Q37106752 | Downregulation of coding transmembrane protein 35 gene inhibits cell proliferation, migration and cell cycle arrest in osteosarcoma cells |
| Q34182116 | Expression characteristics of KAI1 and vascular endothelial growth factor and their diagnostic value for hepatocellular carcinoma |
| Q35728113 | Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling |
| Q36948925 | Nm23-H1 was involved in regulation of KAI1 expression in high-metastatic lung cancer cells L9981. |
| Q37701094 | Overexpression of KAI1 inhibits retinoblastoma metastasis in vitro |
| Q37720265 | Overexpression of KAI1/CD82 suppresses in vitro cell growth, migration, invasion and xenograft growth in oral cancer |
| Q37370796 | RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells |
| Q41387582 | Relationship between the expression of CD133, HIF-1α, VEGF and the proliferation and apoptosis in hypoxic human prostate cancer cells |
| Q38750232 | Silencing of ST6Gal I enhances colorectal cancer metastasis by down-regulating KAI1 via exosome-mediated exportation and thereby rescues integrin signaling |
| Q38579796 | Tetraspanin CD82: a suppressor of solid tumors and a modulator of membrane heterogeneity. |
| Q26782593 | The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targets |
| Q35832242 | The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1. |
| Q64917560 | c-Src is required for hypoxia-induced metastasis-associated functions in prostate cancer cells. |
Search more.